Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
197
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia

Jean-Baptiste FraisonInternal Medicine Department, Sete Hospital, Seite, France;
,
Eric GrignanoHematology Medicine Department, Cochin Hospital, Paris, France;
,
Thorsten BraunHematology Medicine Department, Avicenne Hospital, Bobigny, France;
,
Lionel AdèsHematology Medicine Department, Saint Louis Hospital, Paris, France;
,
Sylvie Chollet-MartinImmunology Department, Cochin Hospital, Paris, France;
,
Pascale Roland-NicaiseImmunology Department, Cochin Hospital, Paris, France;
,
Pierre FenauxHematology Medicine Department, Saint Louis Hospital, Paris, France;
,
Olivier FainSorbonne University, Internal Medicine Department, Saint Antoine Hospital, Paris, France; ;Sorbonne Universités, Paris, France
&
Arsène MekinianSorbonne University, Internal Medicine Department, Saint Antoine Hospital, Paris, France; ;Sorbonne Universités, Paris, FranceCorrespondence[email protected]
 show all
Pages 2594-2596 | Received 11 Jan 2019, Accepted 17 Mar 2019, Published online: 08 Apr 2019

References

  • Mekinian A, Grignano E, Braun T, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300.
  • de Hollanda A, Beucher A, Henrion D, et al. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken). 2011;63:1188–1194.
  • Al Ustwani O, Ford LA, Sait SJ, et al. Myelodysplastic syndromes and autoimmune diseases-case series and review of literature. Leuk Res. 2013;37:894–899.
  • Goodyear OC, Dennis M, Jilani NY, et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood. 2012;119:3361–3369.
  • Fraison J-B, Mekinian A, Grignano E, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–17.
  • Frietsch JJ, Dornaus S, Neumann T, et al. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. Eur J Haematol. 2014;93:247–259.
  • Hamidou MA, Derenne S, Audrain MA, et al. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology (Oxford). 2000;39:417–420.
  • Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol. 1996;33:150–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.